Tech Company Financing Transactions
Cori Clinical Funding Round
Breega, Bynd Venture Capital and Heartfelt participated in a $4 million Seed venture round for Cori Clinical. This venture round was announced on 10/7/2026.
Transaction Overview
Company Name
Announced On
10/7/2026
Transaction Type
Venture Equity
Amount
$4,000,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate product development, expand delivery capacity, deepen regulatory and clinical intelligence in its platform, and support growth across its clinical, engineering, and commercial teams.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
Fora, York House, 221 Pentonville Road
London, N1 9UZ
UK
London, N1 9UZ
UK
Phone
Website
Email Address
Overview
Cori Clinical is an AI workspace which brings together the knowledge an organisation has developed through years of clinical trial experience and combines it with external intelligence from clinical-trial registries, regulatory guidance and public sources including Food and Drug Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA) and European Medicines Agency (EMA). Cori helps clinical teams turn an initial trial brief into a full protocol, submission package and operational plans, built against current regulatory guidance. Rather than addressing a single document or workflow, Cori helps teams build and maintain a living blueprint for a feasible and executable trial.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 10/7/2026: Ledgebrook venture capital transaction
Next: 10/7/2026: Furientis venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








